Key findings• Lung transplant recipients with higher preoperative Nutrition Risk Screening 2002 scores and longer postoperative mechanical ventilation ...

The full billed price for a double lung transplant for a patient under 65 increased 81% between 2020 and this year, to $2.3 ...

The following is a summary of “Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies ...

Last year saw an increase in the number of organ donors, but as donors age and families refuse permission, fewer Australians are receiving life-saving donations.

A NEW trial led by NHS Blood and Transplant and Queen Mary University of London has started investigating whether giving a clotting factor to people who bleed after heart surgery will help save and ...

Oncocyte Corp., a diagnostics technology company, plans to use $29.1 million in new funds to drive development and ...

The Vatican announced that Pope Francis is battling double pneumonia, which has led to breathing difficulties. His infection ...

The Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly ...

Adam Messer traded one Dell hospital for another when he became the president of Dell Children's Medical Center this month.

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...

The rising global cancer incidence is a key factor driving the CD47 inhibitors market, as the demand for novel therapies grows. Recent clinical trial ...